the market?
The Medicines Company
NASDAQ: MDCO
33.71
-1.90
(-5.34%)
| Today's Open | $36.26 |
|---|---|
| Previous Close | $35.61 |
| Daily Range | $28.63 - $36.96 |
| 52-Week Range | $20.04 - $37.40 |
| Market Cap | $1.9B |
| P/E Ratio | 61.40 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,467,281 |
| Average Daily Volume | 826,738 |
| Current FY EPS | $0.93 |
How do you think MDCO
will perform against the market?
Top MDCO Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
February 20, 2009
It's not clear to me why Medicines has fallen so far despite a relatively stable financial picture. Angiomax revenues have been increasing and generics will not be available before 2010 at the earlies … More
News & Commentary
Why The Medicines Company May Be About to Take Off
Don't just ask, "How much inventory?" Ask, "What kind?"The Medicines Company Beats on Both Top and Bottom Lines
Just the facts, Fool.Powerful Cholesterol-Lowering Drugs on Their Way
However, these newcomers won't replace statins.Don't Get Too Worked Up Over The Medicines Company's Latest Numbers
Don't just ask, "How much inventory?" Ask, "What kind?"Medicines Crushes Earnings Estimates
Just the facts, Fool.A Cholesterol-Treatment Contender Partners Up
Alnylam and The Medicines Company join forces.Sector
Healthcare
Industry
Drugs
The Medicines Company (MDCO) Description
A pharmaceutical company provides innovative, cost effective acute care hospital products to the worldwide hospital marketplace. Website: http://www.themedicinescompany.com/
CEO Rating by Glassdoor
More details for The Medicines Company Jobs
The Medicines Company reviews from employees
